• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Comment on "Psoriasis, COVID-19, and acute respiratory distress syndrome: Focusing on the risk of concomitant biological treatment".关于《银屑病、COVID-19与急性呼吸窘迫综合征：关注生物治疗联合应用的风险》的评论
Dermatol Ther. 2020 Nov;33(6):e13840. doi: 10.1111/dth.13840. Epub 2020 Jul 6.
2
Psoriasis, COVID-19, and acute respiratory distress syndrome: Focusing on the risk of concomitant biological treatment.银屑病、新冠病毒肺炎与急性呼吸窘迫综合征：关注联合生物治疗的风险
Dermatol Ther. 2020 Jul;33(4):e13706. doi: 10.1111/dth.13706. Epub 2020 Jun 19.
3
Understanding COVID-19 Acute Respiratory Distress Syndrome.了解新型冠状病毒肺炎急性呼吸窘迫综合征
Ann Am Thorac Soc. 2022 Jan;19(1):150. doi: 10.1513/AnnalsATS.202104-486LE.
4
Commentary: Post-COVID-19 acute respiratory distress syndrome and post-COVID-19 fibrosis-the new kids in town.评论：新冠后急性呼吸窘迫综合征和新冠后肺纤维化——新出现的情况。
J Thorac Cardiovasc Surg. 2022 Mar;163(3):869-870. doi: 10.1016/j.jtcvs.2021.06.040. Epub 2021 Jun 25.
5
The Pressure Paradox: Abdominal Compression to Detect Lung Hyperinflation in COVID-19 Acute Respiratory Distress Syndrome.压力悖论：腹部按压检测新型冠状病毒肺炎急性呼吸窘迫综合征中的肺过度充气
Am J Respir Crit Care Med. 2022 Jan 15;205(2):245-247. doi: 10.1164/rccm.202104-1062IM.
6
Acute respiratory distress syndrome (ARDS) caused by the novel coronavirus disease (COVID-19): a practical comprehensive literature review.新型冠状病毒病（COVID-19）所致急性呼吸窘迫综合征（ARDS）：实用综合文献复习。
Expert Rev Respir Med. 2021 Feb;15(2):183-195. doi: 10.1080/17476348.2020.1820329. Epub 2020 Oct 18.
7
The hyperdynamic circulatory profile of patients with COVID-19-related acute vascular distress syndrome. Letter regarding the article 'Haemodynamic characteristics of COVID-19 patients with acute respiratory distress syndrome requiring mechanical ventilation. An invasive assessment using right heart catheterization'.新型冠状病毒肺炎相关急性血管窘迫综合征患者的高动力循环特征。关于文章《需要机械通气的新型冠状病毒肺炎急性呼吸窘迫综合征患者的血流动力学特征。采用右心导管插入术的侵入性评估》的信函
Eur J Heart Fail. 2021 Mar;23(3):493. doi: 10.1002/ejhf.2089. Epub 2021 Feb 23.
8
COVID-19-related Acute Respiratory Distress Syndrome: Not So Atypical.新型冠状病毒肺炎相关急性呼吸窘迫综合征：并非那么不典型。
Am J Respir Crit Care Med. 2020 Aug 15;202(4):622-624. doi: 10.1164/rccm.202004-1423LE.
9
COVID-19 related acute respiratory distress syndrome: Pathological, radiological and clinical concordance.COVID-19 相关的急性呼吸窘迫综合征：病理、影像学和临床的一致性。
Tuberk Toraks. 2021 Sep;69(3):360-368. doi: 10.5578/tt.20219708.
10
Aspirin in Coronavirus Disease 2019-Related Acute Respiratory Distress Syndrome: An Old, Low-Cost Therapy With a Strong Rationale.阿司匹林用于2019冠状病毒病相关急性呼吸窘迫综合征：一种有充分理论依据的古老且低成本的治疗方法。
Anesth Analg. 2021 Apr 1;132(4):927-929. doi: 10.1213/ANE.0000000000005408.

引用本文的文献

1
Global impact on dermatology practice due to the COVID-19 pandemic.由于 COVID-19 大流行对皮肤科实践的全球影响。
Clin Dermatol. 2021 May-Jun;39(3):479-487. doi: 10.1016/j.clindermatol.2021.01.017. Epub 2021 Feb 2.
2
The COVID-19 pandemic and its skin effects.新型冠状病毒肺炎疫情及其皮肤表现。
Can Fam Physician. 2021 Aug;67(8):582-587. doi: 10.46747/cfp.6708582.
3
Acute generalized exanthematous pustulosis following treatment with favipiravir in a patient with COVID-19 without hydroxychloroquine use: Report of the first case.在未使用羟氯喹的新冠肺炎患者中，法匹拉韦治疗后发生急性泛发性脓疱性皮病：首例病例报告
J Cosmet Dermatol. 2021 Aug;20(8):2387-2389. doi: 10.1111/jocd.14304. Epub 2021 Jun 27.

本文引用的文献

1
Psoriasis, COVID-19, and acute respiratory distress syndrome: Focusing on the risk of concomitant biological treatment.银屑病、新冠病毒肺炎与急性呼吸窘迫综合征：关注联合生物治疗的风险
Dermatol Ther. 2020 Jul;33(4):e13706. doi: 10.1111/dth.13706. Epub 2020 Jun 19.
2
Evolution of COVID-19 infection in four psoriatic patients treated with biological drugs.4例接受生物制剂治疗的银屑病患者的新型冠状病毒肺炎感染演变情况
J Eur Acad Dermatol Venereol. 2020 Aug;34(8):e360-e361. doi: 10.1111/jdv.16587. Epub 2020 Jun 8.
3
Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biologic treatment and renal transplant recipients in maintenance immunosuppressive treatment.接受生物治疗的慢性斑块状银屑病患者以及接受维持性免疫抑制治疗的肾移植受者感染新型冠状病毒肺炎（COVID-19）后住院和死亡的风险。
J Am Acad Dermatol. 2020 Jul;83(1):285-287. doi: 10.1016/j.jaad.2020.04.085. Epub 2020 Apr 21.
4
Biologics for psoriasis patients in the COVID-19 era: more evidence, less fears.新冠疫情时代银屑病患者使用生物制剂：证据增多，恐惧减少。
J Dermatolog Treat. 2020 Jun;31(4):328-329. doi: 10.1080/09546634.2020.1757605. Epub 2020 Apr 27.
5
Novel Coronavirus Disease (COVID-19) and Biologic Therapy in Psoriasis: Infection Risk and Patient Counseling in Uncertain Times.新型冠状病毒肺炎（COVID-19）与银屑病的生物治疗：不确定时期的感染风险及患者咨询
Dermatol Ther (Heidelb). 2020 Apr 16;10(3):339-349. doi: 10.1007/s13555-020-00377-9. eCollection 2020 Jun.
6
Antipsoriatic treatments during COVID-19 outbreak.新冠疫情期间的银屑病治疗
Dermatol Ther. 2020 Jul;33(4):e13345. doi: 10.1111/dth.13345. Epub 2020 Apr 10.
7
COVID-19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action.新型冠状病毒肺炎与银屑病：是时候限制免疫抑制剂的使用了吗？呼吁采取行动。
Dermatol Ther. 2020 Jul;33(4):e13298. doi: 10.1111/dth.13298. Epub 2020 Mar 22.
8
Reducing mortality from 2019-nCoV: host-directed therapies should be an option.降低2019新型冠状病毒所致死亡率：宿主导向疗法应成为一种选择。
Lancet. 2020 Feb 22;395(10224):e35-e36. doi: 10.1016/S0140-6736(20)30305-6. Epub 2020 Feb 5.
9
Safety and effectiveness of conventional systemic therapy and biological drugs in patients with moderate to severe psoriasis and HIV infection: a retrospective multicenter study.中重度银屑病合并 HIV 感染患者接受常规全身治疗和生物制剂治疗的安全性和有效性：一项回顾性多中心研究。
J Dermatolog Treat. 2019 Aug;30(5):461-465. doi: 10.1080/09546634.2018.1535690. Epub 2018 Nov 28.
10
Psoriasis treatment in HIV-positive patients: a systematic review of systemic immunosuppressive therapies.HIV阳性患者的银屑病治疗：系统性免疫抑制疗法的系统评价
Cutis. 2018 Jan;101(1):38;42;56.

Comment on "Psoriasis, COVID-19, and acute respiratory distress syndrome: Focusing on the risk of concomitant biological treatment".

作者信息

Farabi Banu, Bhargava Shashank, Goldust Mohamad, Atak Mehmet Fatih

机构信息

Department of Dermatology, Robert Wood Johnson Medical Center, Rutgers University, New Brunswick, New Jersey, USA.

Department of Dermatology, Ankara University School of Medicine, Ankara, Turkey.

出版信息

Dermatol Ther. 2020 Nov;33(6):e13840. doi: 10.1111/dth.13840. Epub 2020 Jul 6.

DOI:10.1111/dth.13840
PMID:32536009
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7323095/
Abstract
摘要